Novo Nordisk’s One-Time Windfall Masks a Deeper Squeeze as Pipeline Bets Take Shape
Novo Nordisk’s Q1 profit surged on a one-off accounting gain, but US sales fell 11% amid pricing pressure.…
Novo Nordisk’s Wegovy Pill Rewrites the Launch Playbook, but a One-Time Windfall Skews the Numbers
Oral Wegovy prescriptions top 2 million in Q1, sales nearly double estimates at $354M. Novo Nordisk raises guidance…